Watch Ticker

Processa Pharmaceuticals, Inc. Common

Go to Processa Pharmaceuticals, Inc. Common Website

$0.23

0.00 (-1.95%)
Live
Previous Close

$0.231

Day Range

$0.2242 - $0.2346

Previous Day Range

$0.209 - $0.238

Market Cap

$8.5 million USD

Day Vol.

3.4 million

Previous Day Vol.

8.3 million

Currency

USD

Primary Exchange

Nasdaq

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Processa Pharmaceuticals announced the acceptance of three abstracts for the 2025 ASCO Annual Meeting, highlighting its pipeline of Next Generation Cancer (NGC) drug candidates, including PCS6422 (NGC-Cap) and PCS11T (NGC-Iri).

Related tickers: PCSA.

Read Full Article

Processa Pharmaceuticals, a clinical-stage pharmaceutical company, announced its participation in the 2025 BIO CEO & Investor Conference, where it will present a corporate overview and hold one-on-one meetings with investors.

Related tickers: PCSA.

Read Full Article
Trending Tickers

Please sign in to view